Pharmaceutical and life science companies turn to Goodwin to address all of their most important competition-related issues. Our antitrust lawyers are deeply immersed in the scientific, regulatory, financial and commercial challenges faced by our deep roster of life sciences clients. We combine this understanding of the industry with expertise in all aspects of antitrust law to address our clients’ needs.
The antitrust authorities across the globe have increased their scrutiny of transactions — whether M&A or collaboration-style transactions. Goodwin’s antitrust team has advised life sciences companies in countless collaboration agreements and M&A transactions. As lifecycle lawyers, our antitrust support starts even before there is a transaction in order to help our clients structure business solutions and agreements that will minimize the risks associated with antitrust review.
In addition to merger clearance and transactional support, our antitrust lawyers provide counseling on antitrust compliance, strategic business issues, patent litigation settlements, citizen petitions, potential antitrust claims in relations to the misuse of Risk Evaluation and Mitigation Strategy (REMS) policies to delay generic entry, product hopping and other competition issues.
When potential disputes arise, Goodwin’s antitrust team brings to bear its deep experience litigating and advising life sciences clients on matters involving monopolization claims between competitors, licensing, sham litigation, settlement of IP litigation, reverse payments and patent hold-up with standard setting organizations, among other types of disputes.